Period Ending | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
---|---|---|---|---|
Total Revenue | 1,535 | 1,000 | 1,022 | 2,757 |
Cost of Revenue | -- | -- | -- | -- |
Gross Profit | 1,535 | -- | -- | -- |
Operating Expenses | ||||
Research Development | 36,936 | 16,956 | 24,083 | 23,000 |
Selling General and Administrative | 7,310 | 6,445 | 6,026 | 3,874 |
Non Recurring | -- | -- | -- | -- |
Others | 0 | 0 | 0 | 0 |
Total Operating Expenses | 44,246 | 23,401 | 30,109 | 26,874 |
Operating Income or Loss | (42,711) | (22,401) | (29,087) | (24,117) |
Income from Continuing Operations | ||||
Total Other Income/Expenses Net | (796) | (9) | (951) | 1,592 |
Earnings Before Interest And Taxes | (41,915) | (22,401) | (29,087) | (24,117) |
Interest Expense | -- | -- | -- | -- |
Income Before Tax | (42,160) | (22,333) | (29,681) | (22,105) |
Income Tax Expense | (28) | -- | -- | -- |
Minority Interest | -- | -- | -- | -- |
Net Income From Continuing Ops | (42,193) | (22,333) | (29,681) | (22,105) |
Non-recurring Events | ||||
Discontinued Operations | -- | -- | -- | -- |
Extraordinary Items | -- | -- | -- | -- |
Effect Of Accounting Changes | -- | -- | -- | -- |
Other Items | 0 | 0 | 0 | 0 |
Net Income | (42,193) | (22,333) | (29,681) | (22,105) |
Preferred Stock And Other Adjustments | 4,127 | -- | -- | 1,357 |
Net Income Applicable To Common Shares | (46,320) | (22,333) | (29,681) | (23,462) |